The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of cetuximab-based neoadjuvant and adjuvant treatment strategies, with or without surgery, in patients with locally very advanced squamous cell carcinoma of the oral cavity.
Pei-Jen Lou
No relevant relationships to disclose
Chun-Ta Liao
No relevant relationships to disclose
Cheng-Ping Wang
No relevant relationships to disclose
Shiang-Fu Huang
No relevant relationships to disclose
Shin-June Cheng
No relevant relationships to disclose
Cheng-Lung Hsu
No relevant relationships to disclose
Chun-Wei Wang
No relevant relationships to disclose
Tung-Chieh Chang
No relevant relationships to disclose
Ya-Fang Chen
No relevant relationships to disclose
Chien-Yu Lin
No relevant relationships to disclose
Hung-Ming Wang
No relevant relationships to disclose
Ruey-Long Hong
No relevant relationships to disclose